查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828055

2025年女性生育力与快速妊娠检测全球市场报告

Female Fertility And Pregnancy Rapid Test Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，女性生育和快速妊娠测试市场规模强劲成长，从2024年的14亿美元增加到2025年的14.8亿美元，复合年增长率为5.2%。预测期内的增长可归因于生殖健康意识的增强、生育延迟、文化和社会变革、母亲年龄增长以及商店供应的增加。

预计未来几年女性生育和快速妊娠检测市场规模将强劲成长，到2029年将达到19.3亿美元，复合年增长率为7.0%。预测期内的增长可归因于个人化医疗方法、人们对自然计划生育日益增长的兴趣、全球不孕症治疗旅游、政府计划生育倡议以及对平价医疗的努力。预测期内的主要趋势包括数位健康整合、远端医疗的普及、医疗保健产业的伙伴伙伴关係与合作、检测套组的线上零售管道以及排卵预测测试的创新。

快速女性生育力和怀孕测试是一种检测女性生育力和怀孕情况的方法，可以使用药局出售的尿液检查或在医生检查室进行的血液测试。这些快速检测套组提供了一种简单易用的不孕症检测解决方案，旨在检测女性排卵并诊断不孕症。

我们主要的女性生育力和怀孕快速检测套组产品包括不孕不育快速检测套组和怀孕快速检测套组。生育力快速检测试剂盒是一种体外诊断工具，旨在在几分钟内定性地识别和评估怀孕、可孕週期、排卵和精子数量。这些设备有多种规格，包括电子指示仪和线指示仪，可用于 FSH尿液检查检查、LH尿液检查检查、HCG 血液检测和 HCG尿液检查检查等检测。这些套件可透过各种分销管道购买，包括医院、零售店和线上平台。

2025年春季，美国关税上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

女性生育和妊娠快速检测市场研究报告是商业研究公司 (The Business Research Company) 最新报告系列之一，提供女性生育和妊娠快速检测市场统计数据，例如全球市场规模、区域份额、竞争对手在女性生育和妊娠快速检测市场的份额、详细的女性生育和妊娠快速检测细分市场、市场趋势以及女性生育和妊娠快速检测行业的商机。这份女性生育和妊娠快速检测市场研究报告对该行业的现状和未来情况进行了详细分析，为您提供所需的一切观点。

我们预测未来五年该市场将成长7.0%，较先前预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。这种影响可能会直接影响美国，导致来自印度和丹麦等主要地区的单株抗体试纸和侧流膜材料供应链中断，从而导致家用检测服务减少，生殖健康产品价格上涨。此外，由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

妇科疾病盛行率的上升预计将推动女性生育和快速妊娠检测市场的成长。妇科疾病影响女性生殖系统，包括影响子宫、卵巢、阴道和其他相关器官的各种疾病。透过测试诊断与不孕症相关的问题可以解决不孕症问题并减轻妇科疾病的影响。根据美国国家医学图书馆 2022 年 7 月的报告，常见的妇科疾病包括子宫肌瘤、自然流产、卵巢功能障碍、卵巢异位症、多囊性卵巢症候群和月经。因此，由于此类疾病的发生率不断上升，女性生育和快速怀孕检测市场正在经历成长。

预计未来几年，不断增长的医疗保健支出将推动女性生育和快速妊娠检测市场的成长。医疗保健支出是指在特定时期内分配给医疗保健产品和服务的总财政资源，通常是在国家或机构层级。医疗保健投资的增加刺激了生殖健康的研发，从而带来技术进步、改善检测管道以及更全面的生殖保健方法，使个人和医疗保健系统都受益。例如，根据美国机构医疗保险和医疗补助服务中心发布的 2021-2030 年国家卫生支出 (NHE) 报告，预计 2021 年至 2030 年期间国家医疗保健支出将以年均 5.1% 的速度增长，达到约 6.8 兆美元。此外，医疗保险支出预计将以年均 7.2% 的速度成长，而医疗补助支出预计在此期间将以年均 5.6% 的速度成长。因此，医疗保健支出的增加正在推动女性生育和快速妊娠测试市场的扩张。

女性生育和快速妊娠检测市场的一个共同趋势是产品创新，尤其是创新检测套组的开发。主要企业正专注于创造新颖的解决方案，以提升其市场占有率。例如，总部位于以色列的研发公司 Salignostics 于 2022 年 11 月推出了基于唾液的怀孕检测 Salistick。 Salistick 是一种开创性的基于唾液的快速妊娠检测，它透过识别唾液中存在的妊娠激素 (HCG) 来检测早期妊娠，具有改进的使用者介面和高准确度。该套件的技术允许使用者收集唾液进行测试并在 10 分钟内获得结果，透过创新方法提供便利和快速的怀孕检测。

女性生育和快速妊娠检测市场的主要企业正专注于创新产品，例如家用生育检测套组，旨在让人们舒适地在家中评估生育状况。家用生育检测套组是一种设备或套件，旨在让人们无需去诊所即可自行采集样本并分析荷尔蒙水平和生殖健康指标。例如，2022 年 1 月，总部位于纽约的生育诊所和家庭建设福利提供者网路 Kind Body 推出了 Kind at Home 生育测试。此检测套组可全面评估性和生育状况，只需在家中刺破手指即可进行。结果可在几天内获得，并可透过专有的 Kind Body 平台存取。

2022年5月，总部位于英国的女性健康公司Hertility收购了Grip，收购金额未揭露。此次收购旨在拓展Hertility的荷尔蒙检测能力，并增强其生殖健康服务，从而实现更准确的评估，并改善不孕症治疗的患者预后。 Grip总部位于荷兰，专注于荷尔蒙分析和生殖健康的创新解决方案。

女性生育力和快速妊娠检测市场涵盖套件检测女性妊娠和不孕症的尿液检查和血液检测套组的销售。该市场的价值指的是“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球女性生育能力和快速妊娠测试：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球女性生育与妊娠快速检测市场：成长率分析
  • 全球女性生育与妊娠快速检测市场表现：规模与成长，2019-2024
  • 全球女性生育与怀孕快速检测市场预测：规模与成长，2024-2029 年，2034 年
  • 全球女性生育力和快速妊娠测试：总目标市场（TAM）

第六章 市场细分

  • 全球女性生育力和妊娠快速检测市场（按产品、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 不孕不育快速检测套组
  • 快速妊娠检测套组
  • 全球女性生育力和妊娠快速检测市场（按设备类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 数位装置
  • 线路指示器
  • 全球女性生育力和妊娠快速检测市场（按检测类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • FSH尿液检查
  • 尿液促黄尿液检查
  • hCG 血液测试
  • hCG尿液检查
  • 全球女性生育力及怀孕快速检测市场（依通路、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院频道
  • 零售通路
  • 线上通路
  • 全球女性生育力与怀孕快速检测市场：生育力快速检测套组细分市场、类型、效能及预测（2019-2024 年、2024-2029 年、2034 年）
  • 排卵预测套件
  • 黄体激素（LH）检测套组
  • 滤泡刺激素（FSH）检测套组
  • 全球女性生育力与妊娠快速检测市场：快速妊娠检测套组细分、类型、性能及预测（2019-2024、2024-2029、2034）
  • 尿液检查妊娠试验
  • 血液妊娠试验
  • 妊娠及不孕症综合检测

第七章 区域和国家分析

  • 全球女性生育力和怀孕快速检测市场（按地区、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 全球女性生育力与怀孕快速检测市场：国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 女性生育与快速妊娠测试市场：竞争格局
  • 女性生育与妊娠快速检测市场：公司简介
    • Abbott Laboratories
    • Atlas Medical GmbH
    • bioMerieux SA
    • Church & Dwight Co. Inc.
    • Quidel Corporation

第31章：其他领先和创新企业

  • Egens Group
  • Eurofins Scientific SE
  • Everlywell Inc.
  • Genea Pty Limited
  • Geratherm Medical AG
  • SA Scientific Ltd.
  • Artron Laboratories Inc.
  • PRIMA Lab SA
  • The Procter & Gamble Company
  • Alere Inc.
  • Prestige Brands Holdings Inc.
  • SPD Swiss Precision Diagnostics GmbH
  • Fairhaven Health LLC
  • Fertility Focus Limited
  • HiLin Life Products Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年女性生育力与快速怀孕检测市场：提供新机会的国家
  • 2029年女性生育力与快速妊娠检测市场：细分市场带来新机会
  • 2029年女性生育力与快速妊娠检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r23357u

The female fertility and pregnancy rapid tests involve methods for testing fertility and pregnancy in women, utilizing drugstore-bought urine tests and blood tests conducted at a doctor's office. These rapid test kits offer a straightforward and user-friendly solution for fertility testing, aiming to detect ovulation and diagnose infertility in females.

The primary products in the female fertility and pregnancy rapid tests category include fertility rapid test kits and pregnancy rapid test kits. Fertility rapid tests are in vitro diagnostic tools designed for the qualitative identification and assessment of pregnancy, fertility cycles, ovulation, and sperm counts within minutes. These devices come in various forms, including digital devices and line-indicator devices, and can be utilized for tests such as FSH urine test, LH urine test, HCG blood testing, and HCG urine testing. These kits are available through different distribution channels, including hospitals, retail outlets, and online platforms.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The female fertility and pregnancy rapid test market research report are one of a series of new reports from The Business Research Company that provides female fertility and pregnancy rapid test market statistics, including female fertility and pregnancy rapid test industry global market size, regional shares, competitors with a female fertility and pregnancy rapid test market share, detailed female fertility and pregnancy rapid test market segments, market trends and opportunities, and any further data you may need to thrive in the female fertility and pregnancy rapid test industry. This female fertility and pregnancy rapid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The female fertility and pregnancy rapid test market size has grown strongly in recent years. It will grow from $1.4 billion in 2024 to $1.48 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to increased awareness of reproductive health, delay in childbearing age, cultural and societal changes, rising maternal age, over-the-counter availability.

The female fertility and pregnancy rapid test market size is expected to see strong growth in the next few years. It will grow to $1.93 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to personalized medicine approaches, rising interest in natural family planning, global fertility tourism, government initiatives for family planning, affordable healthcare initiatives. Major trends in the forecast period include digital health integration, telemedicine adoption, partnerships and collaborations in the healthcare industry, online retail channels for test kit sales, innovations in ovulation prediction tests.

The forecast of 7.0% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for monoclonal antibody strips and lateral flow membrane materials, sourced from key regions such as India and Denmark, which could lead to reduced at-home testing availability and higher prices for reproductive health products.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of gynecological disorders is anticipated to drive growth in the female fertility and pregnancy rapid test market. Gynecological disorders affect the female reproductive system and can include various conditions impacting the uterus, ovaries, vagina, and other related organs. Diagnosing fertility-related issues through tests can address infertility problems, reducing the impact of gynecological disorders. According to a July 2022 report by the National Library of Medicine, prevalent gynecological disorders encompass ailments such as uterine fibroids, spontaneous abortion, ovarian dysfunction, endometriosis, polycystic ovary syndrome, and dysmenorrhea. Hence, the market for female fertility and pregnancy rapid tests is experiencing growth due to the increasing occurrence of such disorders.

The rising healthcare expenditure is projected to fuel the growth of the female fertility and pregnancy rapid test market in the coming years. Healthcare expenditure refers to the total financial resources allocated for healthcare goods and services over a specific period, usually at a national or institutional level. Increased investment in healthcare can bolster research and development in reproductive health, leading to advancements in technology, enhanced accessibility to testing, and a more holistic approach to reproductive care, benefiting both individuals and healthcare systems. For example, according to the 2021-2030 National Health Expenditure (NHE) report released by the Centers for Medicare & Medicaid Services, a US-based federal agency, national health spending is expected to grow by an average of 5.1% annually between 2021 and 2030, reaching nearly $6.8 trillion. Additionally, Medicare spending is anticipated to increase at an annual rate of 7.2%, while Medicaid spending is projected to grow by 5.6% per year during this period. As a result, the rising healthcare expenditure is driving the expansion of the female fertility and pregnancy rapid test market.

A prevailing trend in the female fertility and pregnancy rapid test market is product innovation, particularly in the development of innovative test kits. Leading companies are focusing on creating novel solutions to fortify their market presence. For instance, in November 2022, Salignostics, an Israel-based research and development firm, introduced Salistick, a saliva-based pregnancy test. Salistick is a pioneering rapid saliva-based pregnancy test that offers improved user interface and high accuracy in detecting early pregnancy by identifying the pregnancy hormone (HCG) in saliva. The kit's technology allows users to collect saliva for testing, providing results in less than 10 minutes, offering convenience and quick detection of pregnancy using an innovative approach.

Major enterprises within the female fertility and pregnancy rapid test market are concentrating on innovative offerings, such as home fertility test kits, aimed at providing enhanced fertility status assessments within the comfort of one's home. A home fertility test kit refers to a device or kit designed for individuals to self-collect samples and analyze hormone levels or reproductive health indicators without visiting a medical facility. For example, in January 2022, Kindbody, a New York-based provider of fertility clinic networks and family-building benefits, introduced the Kind at Home fertility test. This test kit offers a comprehensive assessment of fertility status for both men and women, obtained conveniently from home through a straightforward finger prick. Within a few days, users receive their results and tailored recommendations accessible via the proprietary Kindbody patient platform.

In May 2022, Hertility, a UK-based women's health company, acquired Grip for an undisclosed sum. This acquisition aims to expand Hertility's hormone testing capabilities and strengthen its reproductive health services, allowing for more precise assessments and improved patient outcomes in fertility management. Grip, a Netherlands-based company, specializes in innovative solutions for hormone analysis and reproductive health.

Major companies operating in the female fertility and pregnancy rapid test market include Abbott Laboratories, Atlas Medical GmbH, bioMerieux SA, Church & Dwight Co. Inc., Quidel Corporation, Egens Group, Eurofins Scientific SE, Everlywell Inc., Genea Pty Limited, Geratherm Medical AG, SA Scientific Ltd., Artron Laboratories Inc., PRIMA Lab SA, The Procter & Gamble Company, Alere Inc., Prestige Brands Holdings Inc., SPD Swiss Precision Diagnostics GmbH, Fairhaven Health LLC, Fertility Focus Limited, HiLin Life Products Inc., Inverness Medical Innovations Inc., UEBE Medical GmbH, Wondfo Biotech Co. Ltd.

North America was the largest region in the female fertility and pregnancy rapid test market in 2024. The regions covered in the female fertility and pregnancy rapid test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the female fertility and pregnancy rapid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The female fertility and pregnancy rapid test market consists of sales of urine and blood test kits used to detect female pregnancy and fertility. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Female Fertility And Pregnancy Rapid Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on female fertility and pregnancy rapid test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for female fertility and pregnancy rapid test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The female fertility and pregnancy rapid test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Fertility Rapid Test Kits; Pregnancy Rapid Test Kits
  • 2) By Device Type: Digital Devices; Line-indicator Devices
  • 3) By Test Type: FSH Urine Test; LH Urine Test; hCG Blood Test; hCG Urine Test
  • 4) By Distribution Channel: Hospital Channel; Retail Channel; Online Channel
  • Subsegments:
  • 1) By Fertility Rapid Test Kits: Ovulation Predictor Kits; Luteinizing Hormone (LH) Test Kits; Follicle-Stimulating Hormone (FSH) Test Kits
  • 2) By Pregnancy Rapid Test Kits: Urine-Based Pregnancy Tests; Blood-Based Pregnancy Tests; Combo Fertility And Pregnancy Tests
  • Companies Mentioned: Abbott Laboratories; Atlas Medical GmbH; bioMerieux SA; Church & Dwight Co. Inc.; Quidel Corporation; Egens Group; Eurofins Scientific SE; Everlywell Inc.; Genea Pty Limited; Geratherm Medical AG; SA Scientific Ltd.; Artron Laboratories Inc.; PRIMA Lab SA; The Procter & Gamble Company; Alere Inc.; Prestige Brands Holdings Inc.; SPD Swiss Precision Diagnostics GmbH; Fairhaven Health LLC; Fertility Focus Limited; HiLin Life Products Inc.; Inverness Medical Innovations Inc.; UEBE Medical GmbH; Wondfo Biotech Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Female Fertility And Pregnancy Rapid Test Market Characteristics

3. Female Fertility And Pregnancy Rapid Test Market Trends And Strategies

4. Female Fertility And Pregnancy Rapid Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Female Fertility And Pregnancy Rapid Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Female Fertility And Pregnancy Rapid Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Female Fertility And Pregnancy Rapid Test Market Growth Rate Analysis
  • 5.4. Global Female Fertility And Pregnancy Rapid Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Female Fertility And Pregnancy Rapid Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Female Fertility And Pregnancy Rapid Test Total Addressable Market (TAM)

6. Female Fertility And Pregnancy Rapid Test Market Segmentation

  • 6.1. Global Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fertility Rapid Test KitS
  • Pregnancy Rapid Test Kits
  • 6.2. Global Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Digital Devices
  • Line-indicator Devices
  • 6.3. Global Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • FSH Urine Test
  • LH Urine Test
  • hCG Blood Test
  • hCG Urine Test
  • 6.4. Global Female Fertility And Pregnancy Rapid Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Channel
  • Retail Channel
  • Online Channel
  • 6.5. Global Female Fertility And Pregnancy Rapid Test Market, Sub-Segmentation Of Fertility Rapid Test Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ovulation Predictor Kits
  • Luteinizing Hormone (LH) Test Kits
  • Follicle-Stimulating Hormone (FSH) Test Kits
  • 6.6. Global Female Fertility And Pregnancy Rapid Test Market, Sub-Segmentation Of Pregnancy Rapid Test Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine-Based Pregnancy Tests
  • Blood-Based Pregnancy Tests
  • Combo Fertility And Pregnancy Tests

7. Female Fertility And Pregnancy Rapid Test Market Regional And Country Analysis

  • 7.1. Global Female Fertility And Pregnancy Rapid Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Female Fertility And Pregnancy Rapid Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Female Fertility And Pregnancy Rapid Test Market

  • 8.1. Asia-Pacific Female Fertility And Pregnancy Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Female Fertility And Pregnancy Rapid Test Market

  • 9.1. China Female Fertility And Pregnancy Rapid Test Market Overview
  • 9.2. China Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Female Fertility And Pregnancy Rapid Test Market

  • 10.1. India Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Female Fertility And Pregnancy Rapid Test Market

  • 11.1. Japan Female Fertility And Pregnancy Rapid Test Market Overview
  • 11.2. Japan Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Female Fertility And Pregnancy Rapid Test Market

  • 12.1. Australia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Female Fertility And Pregnancy Rapid Test Market

  • 13.1. Indonesia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Female Fertility And Pregnancy Rapid Test Market

  • 14.1. South Korea Female Fertility And Pregnancy Rapid Test Market Overview
  • 14.2. South Korea Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Female Fertility And Pregnancy Rapid Test Market

  • 15.1. Western Europe Female Fertility And Pregnancy Rapid Test Market Overview
  • 15.2. Western Europe Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Female Fertility And Pregnancy Rapid Test Market

  • 16.1. UK Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Female Fertility And Pregnancy Rapid Test Market

  • 17.1. Germany Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Female Fertility And Pregnancy Rapid Test Market

  • 18.1. France Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Female Fertility And Pregnancy Rapid Test Market

  • 19.1. Italy Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Female Fertility And Pregnancy Rapid Test Market

  • 20.1. Spain Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Female Fertility And Pregnancy Rapid Test Market

  • 21.1. Eastern Europe Female Fertility And Pregnancy Rapid Test Market Overview
  • 21.2. Eastern Europe Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Female Fertility And Pregnancy Rapid Test Market

  • 22.1. Russia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Female Fertility And Pregnancy Rapid Test Market

  • 23.1. North America Female Fertility And Pregnancy Rapid Test Market Overview
  • 23.2. North America Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Female Fertility And Pregnancy Rapid Test Market

  • 24.1. USA Female Fertility And Pregnancy Rapid Test Market Overview
  • 24.2. USA Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Female Fertility And Pregnancy Rapid Test Market

  • 25.1. Canada Female Fertility And Pregnancy Rapid Test Market Overview
  • 25.2. Canada Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Female Fertility And Pregnancy Rapid Test Market

  • 26.1. South America Female Fertility And Pregnancy Rapid Test Market Overview
  • 26.2. South America Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Female Fertility And Pregnancy Rapid Test Market

  • 27.1. Brazil Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Female Fertility And Pregnancy Rapid Test Market

  • 28.1. Middle East Female Fertility And Pregnancy Rapid Test Market Overview
  • 28.2. Middle East Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Female Fertility And Pregnancy Rapid Test Market

  • 29.1. Africa Female Fertility And Pregnancy Rapid Test Market Overview
  • 29.2. Africa Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Female Fertility And Pregnancy Rapid Test Market Competitive Landscape And Company Profiles

  • 30.1. Female Fertility And Pregnancy Rapid Test Market Competitive Landscape
  • 30.2. Female Fertility And Pregnancy Rapid Test Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Atlas Medical GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. bioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Church & Dwight Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Female Fertility And Pregnancy Rapid Test Market Other Major And Innovative Companies

  • 31.1. Egens Group
  • 31.2. Eurofins Scientific SE
  • 31.3. Everlywell Inc.
  • 31.4. Genea Pty Limited
  • 31.5. Geratherm Medical AG
  • 31.6. SA Scientific Ltd.
  • 31.7. Artron Laboratories Inc.
  • 31.8. PRIMA Lab SA
  • 31.9. The Procter & Gamble Company
  • 31.10. Alere Inc.
  • 31.11. Prestige Brands Holdings Inc.
  • 31.12. SPD Swiss Precision Diagnostics GmbH
  • 31.13. Fairhaven Health LLC
  • 31.14. Fertility Focus Limited
  • 31.15. HiLin Life Products Inc.

32. Global Female Fertility And Pregnancy Rapid Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Female Fertility And Pregnancy Rapid Test Market

34. Recent Developments In The Female Fertility And Pregnancy Rapid Test Market

35. Female Fertility And Pregnancy Rapid Test Market High Potential Countries, Segments and Strategies

  • 35.1 Female Fertility And Pregnancy Rapid Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Female Fertility And Pregnancy Rapid Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Female Fertility And Pregnancy Rapid Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer